Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Takeda said new Phase 3 LATITUDE Atlas data showed zasocitinib was statistically superior to deucravacitinib across primary and key secondary endpoints. The company also cited durable skin clearance and no new safety signals.
The food and agri group said revenue rose 33% in Q2 to US$1,139 million and 32% in 6M to US$2,161 million. Net profit fell 35% in Q2 to US$28 million.
South Africa's April leading indicator falls to 118.9 from revised 121.1 prior